Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
Journal
Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
27
12
2017
revised:
09
03
2018
accepted:
27
04
2018
pubmed:
20
6
2018
medline:
12
3
2020
entrez:
20
6
2018
Statut:
ppublish
Résumé
Previous genome-wide association studies (GWAS) have identified 42 loci (P < 5 × 10-8) associated with risk of colorectal cancer (CRC). Expanded consortium efforts facilitating the discovery of additional susceptibility loci may capture unexplained familial risk. We conducted a GWAS in European descent CRC cases and control subjects using a discovery-replication design, followed by examination of novel findings in a multiethnic sample (cumulative n = 163 315). In the discovery stage (36 948 case subjects/30 864 control subjects), we identified genetic variants with a minor allele frequency of 1% or greater associated with risk of CRC using logistic regression followed by a fixed-effects inverse variance weighted meta-analysis. All novel independent variants reaching genome-wide statistical significance (two-sided P < 5 × 10-8) were tested for replication in separate European ancestry samples (12 952 case subjects/48 383 control subjects). Next, we examined the generalizability of discovered variants in East Asians, African Americans, and Hispanics (12 085 case subjects/22 083 control subjects). Finally, we examined the contributions of novel risk variants to familial relative risk and examined the prediction capabilities of a polygenic risk score. All statistical tests were two-sided. The discovery GWAS identified 11 variants associated with CRC at P < 5 × 10-8, of which nine (at 4q22.2/5p15.33/5p13.1/6p21.31/6p12.1/10q11.23/12q24.21/16q24.1/20q13.13) independently replicated at a P value of less than .05. Multiethnic follow-up supported the generalizability of discovery findings. These results demonstrated a 14.7% increase in familial relative risk explained by common risk alleles from 10.3% (95% confidence interval [CI] = 7.9% to 13.7%; known variants) to 11.9% (95% CI = 9.2% to 15.5%; known and novel variants). A polygenic risk score identified 4.3% of the population at an odds ratio for developing CRC of at least 2.0. This study provides insight into the architecture of common genetic variation contributing to CRC etiology and improves risk prediction for individualized screening.
Sections du résumé
BACKGROUND
Previous genome-wide association studies (GWAS) have identified 42 loci (P < 5 × 10-8) associated with risk of colorectal cancer (CRC). Expanded consortium efforts facilitating the discovery of additional susceptibility loci may capture unexplained familial risk.
METHODS
We conducted a GWAS in European descent CRC cases and control subjects using a discovery-replication design, followed by examination of novel findings in a multiethnic sample (cumulative n = 163 315). In the discovery stage (36 948 case subjects/30 864 control subjects), we identified genetic variants with a minor allele frequency of 1% or greater associated with risk of CRC using logistic regression followed by a fixed-effects inverse variance weighted meta-analysis. All novel independent variants reaching genome-wide statistical significance (two-sided P < 5 × 10-8) were tested for replication in separate European ancestry samples (12 952 case subjects/48 383 control subjects). Next, we examined the generalizability of discovered variants in East Asians, African Americans, and Hispanics (12 085 case subjects/22 083 control subjects). Finally, we examined the contributions of novel risk variants to familial relative risk and examined the prediction capabilities of a polygenic risk score. All statistical tests were two-sided.
RESULTS
The discovery GWAS identified 11 variants associated with CRC at P < 5 × 10-8, of which nine (at 4q22.2/5p15.33/5p13.1/6p21.31/6p12.1/10q11.23/12q24.21/16q24.1/20q13.13) independently replicated at a P value of less than .05. Multiethnic follow-up supported the generalizability of discovery findings. These results demonstrated a 14.7% increase in familial relative risk explained by common risk alleles from 10.3% (95% confidence interval [CI] = 7.9% to 13.7%; known variants) to 11.9% (95% CI = 9.2% to 15.5%; known and novel variants). A polygenic risk score identified 4.3% of the population at an odds ratio for developing CRC of at least 2.0.
CONCLUSIONS
This study provides insight into the architecture of common genetic variation contributing to CRC etiology and improves risk prediction for individualized screening.
Identifiants
pubmed: 29917119
pii: 5039592
doi: 10.1093/jnci/djy099
pmc: PMC6555904
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
146-157Subventions
Organisme : NCI NIH HHS
ID : R01 CA195789
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK110267
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA137088
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA206110
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074794
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA081488
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207371
Pays : United States
Organisme : NIH HHS
ID : S10 OD020069
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182910
Pays : United States
Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U19 CA148107
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA197350
Pays : United States
Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA188214
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA074794
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA173640
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167551
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA152756
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
Science. 2004 Oct 22;306(5696):636-40
pubmed: 15499007
Nat Genet. 2007 May;39(5):645-9
pubmed: 17401363
Cancer Biol Ther. 2007 Jul;6(7):1143-7
pubmed: 17630503
Nat Genet. 2007 Nov;39(11):1315-7
pubmed: 17934461
Nat Genet. 2008 Dec;40(12):1426-35
pubmed: 19011631
Drug Discov Today Dis Mech. 2007;4(4):293-300
pubmed: 19043597
Nat Genet. 2009 Sep;41(9):986-90
pubmed: 19648918
Am J Hum Genet. 2009 Nov;85(5):679-91
pubmed: 19836008
Nat Genet. 2010 Mar;42(3):224-8
pubmed: 20101243
Nat Biotechnol. 2010 Oct;28(10):1045-8
pubmed: 20944595
Nat Genet. 2010 Nov;42(11):973-7
pubmed: 20972440
Hum Mol Genet. 2011 Jul 15;20(14):2879-88
pubmed: 21531788
Methods Mol Biol. 2011;791:265-86
pubmed: 21913086
Nat Genet. 2011 Oct 30;43(12):1210-4
pubmed: 22037553
Br J Cancer. 2012 Sep 4;107(6):1001-8
pubmed: 22878375
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2
pubmed: 23535731
Hum Mol Genet. 2013 Dec 15;22(24):5048-55
pubmed: 23851122
Carcinogenesis. 2014 Sep;35(9):2039-46
pubmed: 24760461
Nat Genet. 2014 Jun;46(6):533-42
pubmed: 24836286
Nat Genet. 2014 Jul;46(7):731-5
pubmed: 24908248
Hum Mol Genet. 2014 Dec 15;23(24):6616-33
pubmed: 25027329
Nat Commun. 2014 Aug 08;5:4613
pubmed: 25105248
PLoS One. 2014 Nov 06;9(11):e111914
pubmed: 25375357
Gastroenterology. 2015 Jun;148(7):1330-9.e14
pubmed: 25683114
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Nat Commun. 2015 Jul 07;6:7138
pubmed: 26151821
Gut. 2015 Oct;64(10):1623-36
pubmed: 26187503
Hum Genet. 2015 Nov;134(11-12):1249-1262
pubmed: 26404086
Gastroenterology. 2016 Jun;150(7):1633-1645
pubmed: 26965516
Hum Mol Genet. 2016 Jun 1;25(11):2349-2359
pubmed: 27005424
Carcinogenesis. 2016 Jun;37(6):547-556
pubmed: 27207650
Nat Rev Clin Oncol. 2016 Sep;13(9):581-8
pubmed: 27296296
Int J Cancer. 2016 Dec 15;139(12):2655-2670
pubmed: 27459707
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780